Your ASC is your most valuable asset. Do you know what it is actually worth?
Strategic financial guidance for ophthalmologist-owners managing multi-entity practices, equipment decisions, and growth opportunities.
A 4-minute test your accountant hopes you skip.

At a glance
TL;DR — What is a Ophthalmology Fractional CFO?
A fractional CFO for ophthalmology practices provides strategic financial leadership for eye care groups — covering ASC joint venture structures, LASIK vs. medical revenue strategy, and practice valuation for PE or DSO partnerships — typically engaged by ophthalmologist-owners generating $3M–$20M who are making major capital or exit decisions. Sorso is a fractional CFO firm that does this for ophthalmology practices across the US, from $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee.
Industry Context
The Strategic Picture for Ophthalmology Practices
Ophthalmology is one of the most attractive specialties for private equity consolidation. Retina-focused platforms (Retina Consultants of America), general ophthalmology platforms (EyeCare Partners, US Eye, Unifeye Vision Partners, Chicago Pacific Founders), and vision-integrated platforms continue aggressive roll-up activity. FOCUS Investment Banking's April 2026 benchmarks put ophthalmology add-on deals at 6 to 10 times EBITDA and platform deals at 10 to 15 times, and credit ASC ownership with 1 to 3 extra turns. A practice with a partially-owned ASC, strong cataract volume, and retina or oculoplastic subspecialty coverage gets a higher multiple.
The CFO conversations in ophthalmology are unusually capital-intensive. Equipment decisions (femtosecond lasers, phacoemulsification systems, OCT imaging, visual field equipment) are large and lumpy, and each needs a case-volume forecast behind it. Premium IOL programs require pricing strategy, patient financing, and clinical staff training. ASC expansion or acquisition decisions involve regulatory considerations (Certificate of Need in some states), capital structure, and partner economics. These are large capital decisions that need real modeling, not intuition.
Is This Right for You?
This service is for ophthalmology practice owners facing these challenges:
Need accurate books first? Our Accounting service for ophthalmology practices may be a better starting point.
Strategic Pitfalls
CFO-Level Mistakes We See in Ophthalmology Practices
The strategic and capital-allocation errors that cost ophthalmology practice owners the most.
01
Underinvesting in premium IOL penetration
Premium lenses made up about 21 percent of U.S. cataract surgeries in 2025, according to Market Scope data in RxSight's 2025 annual report. Each conversion adds a patient-paid fee that the same filing puts at $2,000 to $5,000 per eye. Counselor training and patient education drive this number more than physician preference.
02
Buying a femtosecond laser without volume modeling
A femtosecond laser is a large capital purchase that also carries a per-case cost for procedure licenses and disposables. An equipment market report cited in LENSAR's 2025 annual report put the industry average at 496 procedures a year per installed laser. Without a realistic volume projection and premium IOL attach rate assumption, the laser can lose money for years. Real ROI analysis is required before purchase.
03
Not monetizing ASC ownership properly
Ophthalmologists often own ASC investor shares but do not track ASC distributions separately from clinical income. When planning an exit, the ASC interest often has significant independent value that owners have not quantified.
04
Accepting the first PE offer without subspecialty analysis
A retina practice attached to a general ophthalmology group may be individually worth more to a retina-focused consolidator than to the general platform bidder. Without knowing which buyers pay most for which subspecialty, owners can leave real money on the table.
05
Under-pricing optical shop services
Optical dispensers and retail pricing is often set based on cost-plus rather than market value. A well-priced optical can earn a high gross margin (in the Management & Business Academy's Key Metrics data, the top 30 percent of independent optometry practices made 66 to 75 percent on eyewear, against a 61 percent median), while one priced below market earns little and adds almost nothing to practice EBITDA.
The Numbers That Matter
CFO Dashboard Metrics for Ophthalmology Practices
Adjusted EBITDA
- Earnings before interest, taxes, depreciation, and amortization with owner compensation normalized.
Combined EBITDA Margin
- Adjusted EBITDA across practice and ASC as a percentage of combined collections.
ASC EBITDA Margin
What we look for: At or above the 29.5 percent operating margin of Pennsylvania ASCs in 2024 (MedPAC)
- ASC net income plus depreciation and amortization, divided by ASC collections.
Premium IOL Revenue
- Non-covered premium lens revenue collected directly from patients.
Equipment ROI Period
What we look for: Under 36 months for major capital
- Months to recoup equipment capital cost through incremental case revenue.
Subspecialty Mix
- Revenue by subspecialty (general, cornea, retina, glaucoma, oculoplastic) as percentage of total.
Days Cash on Hand
What we look for: 60 to 120 days
- Cash reserves divided by average daily operating expenses.
Capital & Vendor Strategy
Equipment, Software, and Partner Decisions
Capital allocation in ophthalmology is particularly complex because decisions span the practice, the optical shop, and the ASC. Each requires different ROI modeling. A femtosecond laser affects practice and ASC economics simultaneously; an optical inventory investment affects only the optical shop; an ASC expansion involves regulatory, capital, and partner considerations.
From an M&A perspective, the subspecialty mix matters enormously. Retina practices trade at premiums because of anti-VEGF drug spread and predictable injection volume. Cataract-heavy general practices with ASC participation trade at premiums because of ASC economics. Glaucoma and medical eye practices trade at lower multiples because of lower margin profile. A CFO guides the owner through understanding which parts of their practice are most valuable to which buyers, and how to position for the most favorable transaction.
What's Included
How a Fractional CFO Works for Ophthalmology Practices
Ophthalmology-specific strategic leadership that goes beyond reporting.
ASC Strategy & Valuation
- •ASC ownership share valuation
- •Capacity expansion vs partner surgeon recruitment analysis
- •ASC syndication and management company evaluation
Capital & Equipment Planning
- •Multi-year equipment replacement and upgrade roadmap
- •Femtosecond laser ROI analysis
- •Diagnostic technology investment prioritization
- •Financing structure optimization
Growth Strategy
- •Premium service line development (premium IOLs, dry eye, cosmetic)
- •Satellite location vs referral network strategy
- •Optometrist partnership models
M&A and Exit Planning
- •Practice valuation with ophthalmology-specific multiples
- •PE platform and add-on analysis
- •Succession planning and partner transitions
Results
Results in this example
| Metric | In this example |
|---|---|
| ASC reallocation | Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit |
| Premium IOL margin | Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually |
| Optical shop improvement | Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually |
Illustrative Scenario
What This Looks Like In Practice
A multi-surgeon ophthalmology practice with ASC ownership, an optical shop, and employed optometrists, combined revenue in the $8M–$10M range. Owner-surgeon take-home was below expectations. Nobody could clearly explain the financial relationship between the practice, the ASC, and the optical shop.
What the review found:
- •ASC cost allocation subsidizing practice overhead by several hundred thousand dollars a year, so the practice looked profitable only because the ASC was absorbing shared costs disproportionately
- •Premium IOL upgrades generating meaningful patient revenue but at a sub-25% margin, driven by untracked implant costs and under-priced upgrade fees
- •The optical shop running at a low-double-digit margin, with frame purchasing fragmented across multiple vendors
- •Anti-VEGF drug waste billing (JW modifier) not being submitted, leaving mid-five figures in unbilled drug waste per year
Representative results
Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit
ASC reallocation
Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually
Premium IOL margin
Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually
Optical shop improvement
The takeaway
The lesson from this example: without clean separation between practice, ASC, and optical, shared costs quietly migrate to whichever entity the GL defaults to. One entity ends up looking healthy while another absorbs the difference.
Think your ophthalmology practice has similar potential?
Common Questions About Fractional CFO for Ophthalmology Practices
How much does a fractional CFO for ophthalmology practices cost?+
Fractional CFO starts at $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee. It usually pays off from about $3M in revenue; below that, accounting from $2,000 a month is the better first step, and we will say so.
Do you also keep the books?+
If you want us to. Sorso's accounting service runs the monthly close, with separate P&Ls for the practice, the ASC and optical, and the CFO work sits on top of it. If you already have a bookkeeper or controller, we work from their books. We are not a CPA firm, so tax filing stays with your CPA.
Do you work with ophthalmology practices in my state?+
Yes. We work with ophthalmology practices across the US. The work runs on your accounting, billing and payroll systems, so where the practice is does not change it.
How do you value an ophthalmology practice with ASC ownership?+
Separately. The practice and ASC have different multiples and different buyer pools. We value each entity, model the combined economics, and help you understand what a buyer is actually paying for.
Should we invest in a femtosecond laser?+
We model the ROI based on your cataract volume, premium IOL conversion rate, and the price you can charge for laser-assisted surgery. The payback period varies enormously based on volume — we calculate yours specifically.
How do you approach PE deals in ophthalmology?+
We analyze the full structure: practice valuation, ASC valuation, retained equity terms, management fees, employment agreements, and earnout provisions. The headline number is often misleading in eye care deals.
Should we bring more surgeons into the ASC?+
We model the impact: additional case volume, shared cost reduction, scheduling constraints, and ownership dilution. More surgeons mean more revenue but also more complexity — the math is specific to your situation.
How do we grow premium service revenue?+
We start with your current premium IOL conversion rate, dry eye treatment revenue, and cosmetic offerings. Then we model the financial impact of improving conversion, adding services, and marketing investment. Small conversion rate improvements drive large revenue changes in ophthalmology.
What is the biggest financial oversight in ophthalmology?+
Ignoring optical shop economics. The optical shop is often treated as a convenience, not a profit center. With good vendor management and pricing it can earn a solid margin, and it needs its own P&L so you can see whether it does.
Stop guessing. Start leading your ophthalmology practice with data.
Take the 4-minute financial assessment—and find out if your ophthalmology practice is ready for strategic CFO leadership.
Curious what you'd actually receive each month? See a sample monthly report →
Sources
Figures on this page come from these published sources. Rows marked Sorso estimate are our own arithmetic on them.
- RxSight, 2025 Form 10-K (Market Scope premium IOL data)
- FTI Consulting, Ophthalmology: A Vision for the Future (2024)
- MedPAC, March 2026 Report to the Congress, ambulatory surgical centers chapter
- FOCUS Investment Banking, Ophthalmology Practice Valuation 2026 Benchmarks
- CMS, JW and JZ modifier policy FAQs
- CMS, Medicare Part B drug payment limit files (October 2026)
- Management & Business Academy, Key Metrics: Assessing Optometric Practice Performance (2015)
- CMS, 2026 Physician Fee Schedule relative value files
Other services for ophthalmology practices
Ophthalmology Practices Accounting
Healthcare-specialized bookkeeping and reporting for ophthalmology practices.
Ophthalmology Practices Revenue Cycle
RCM benchmarks and leak detection for ophthalmology practices.
Medical practice bookkeeping
Medical practice bookkeeping: payer deposits matched to remittances, billing reconciled to the bank, books closed in 15 business days.
Medical practice accountant
A medical practice accountant for clinics and physician groups: monthly books, close and reporting.
Accounting for optometrists
Accounting and bookkeeping for optometry practices, with exam fees, vision plans, medical claims and optical sales kept apart.
By state
Ophthalmology Practices accounting and CFO support, by state
State-level tax, payer, and regulatory context shapes what “good” looks like for ophthalmology practices practices. The pages below walk through each state's specifics.